FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/11/097404 [Registered on: 13/11/2025] Trial Registered Prospectively
Last Modified On: 11/11/2025
Post Graduate Thesis  Yes 
Type of Trial  Observational 
Type of Study   Cross Sectional Study 
Study Design  Single Arm Study 
Public Title of Study   Prevalence of sepsis-associated acute kidney injury and its association with abdominal adipose tissue among patients with Sepsis.  
Scientific Title of Study   Prevalence and association between acute kidney injury and central obesity among patients with sepsis admitted to the critical care units of a tertiary care hospital in Udupi, Karnataka. 
Trial Acronym  nill 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Sweekrity Benjamin 
Designation  Nurse Practitioner in Critical Care 
Affiliation  Manipal Academy of Higher Education, Manipal 
Address  Department of Medical Surgical Nursing, Manipal College of Nursing, MAHE, Manipal.

Udupi
KARNATAKA
576104
India 
Phone  09123155956  
Fax    
Email  sweekrity.mconmpl2024@learner.manipal.edu  
 
Details of Contact Person
Scientific Query
 
Name  Mrs Janet Prameela Dsouza 
Designation  Assistant Professor Senior Scale 
Affiliation  Manipal Academy of Higher Education, Manipal 
Address  Department of Medical Surgical Nursing,1st floor, Manipal College of Nursing, MAHE, Manipal.

Udupi
KARNATAKA
576104
India 
Phone  9986417306  
Fax    
Email  janet.p@manipal.edu  
 
Details of Contact Person
Public Query
 
Name  Mrs Janet Prameela Dsouza 
Designation  Assistant Professor Senior Scale 
Affiliation  Manipal Academy of Higher Education, Manipal 
Address  Department of Medical Surgical Nursing,1st floor, Manipal College of Nursing, MAHE, Manipal.

Udupi
KARNATAKA
576104
India 
Phone  9986417306  
Fax    
Email  janet.p@manipal.edu  
 
Source of Monetary or Material Support  
Kasturba Hospital, Manipal, Karnataka 576104 
 
Primary Sponsor  
Name  Kasturba Hospital Manipal 
Address  Kasturba Hospital Manipal Karnataka India 576104 
Type of Sponsor  Research institution and hospital 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Souvik Chaudhuri  Kasturba Hospital Manipal  ICU1 and ICU2 of Kasturba Hospital, Manipal, karnataka.
Udupi
KARNATAKA 
9937178620

souvik.chaudhuri@manipal.edu 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Kasturba Medical College and Kasturba Hospital Institutional committee 2(student research)  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: N17||Acute kidney failure,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Comparator Agent  Nil  Nil 
Intervention  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  90.00 Year(s)
Gender  Both 
Details  1 Patients aged above 18 years,
2 Patients of sepsis as diagnosed by the SOFA score based on Sepsis 3 criteria and having AKI based on KDIGO guideline criteria (SA-AKI).
3 Admitted or transferred to ICUs
 
 
ExclusionCriteria 
Details  1 Patients with a previously diagnosed chronic kidney disease (CKD) of any stage.
2 Patients presenting with acute kidney injury (AKI) of more than 2 days’ duration (acute kidney disease, AKD), as the cause of AKD will be difficult to ascertain due to limitations in prospective follow-up.
3 Discharge/death/transfer before 24 hrs of ICU admission.

 
 
Method of Generating Random Sequence   Not Applicable 
Method of Concealment   Not Applicable 
Blinding/Masking   Not Applicable 
Primary Outcome  
Outcome  TimePoints 
1. Prevalence of acute kidney injury in sepsis patients
2. Proportion of patients with AKI developing non-resolving AKI and AKD.
3. Association between central obesity and development of AKI

 
Presence or absence of AKI - At baseline (during admission to the hospital)
If AKI is absent - assessment for development of AKI on 1st day of ICU admission, 3rd, and 5th day
Assessment for central obesity - 1st day of ICU admission




 
 
Secondary Outcome  
Outcome  TimePoints 
Nil  Nil 
 
Target Sample Size   Total Sample Size="156"
Sample Size from India="156" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   10/12/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="10"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

About 20% of patients admitted to the ICUs have obesity. Obesity, apart from its well-known cardio-vascular and metabolic adverse effects, also potentiates cytokine release, leading to a low-grade inflammatory state. Obesity has been associated with a higher risk of early SA-AKI, and studies have shown an association between obesity and the development of acute kidney injury (AKI) in patients with critical illness. Though obesity is known to be a risk factor for AKI and CKD, whether it specifically causes SA-AKI has not been extensively studied. Traditionally, the classification of obesity has been based on BMI. However, it is difficult to measure BMI in critically ill ICU patients to determine obesity class, as equipment to measure the weights in supine patients is often unavailable in resource-limited settings.The purpose of the study is to determine if central obesity (as assessed by B-mode ultrasound of intra-abdominal fat thickness and pre-peritoneal fat thickness) is associated with AKI in patients with sepsis. Investigating this association could reveal potential biomarkers or therapeutic targets to enhance patient outcomes in a critical care environment.

 
Close